[1]
Gama, R.N. da . et al. 2020. A framework for decision making of migraine treatment with anti- CGRP monoclonal antibodies: a guide for real-world practice and public policies. Headache Medicine. 11, 3 (Sep. 2020), 72–76. DOI:https://doi.org/10.48208/HeadacheMed.2020.20.